Mark Lipton
Research Subjects
Mark Lipton has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
A D Boyd
1 shared publicationA T Culliford
1 shared publicationAlfred T. Culliford
1 shared publicationAndrea V. Mba Papa
1 shared publicationBrian M. Wyatt
1 shared publication- Eric Goldberg
Division of Gastroenterology, University of Maryland Medical Center, Baltimore, MD, USA
1 shared publication
Latest Publications
- 1 September 2012
- Published by Wolters Kluwer Health in CIN: Computers, Informatics, Nursing
- Vol. 30 (9) , 503-509
Perceptions of Health Information Exchange in Home Healthcare
The aim of this study was to understand home healthcare nurses’ current experiences in obtaining outside clinical information at the point of care and the type of clinical information they most desire in their patients’ health information exchange profile. A Web-based survey was deployed to home health workers in New York to learn about their experiences retrieving outside clinical data prior to having access to health information exchange, preferred data elements and sources in their patients’ health information exchange profiles, and how availability of outside clinical data may affect emergency department referrals. Of the 2383 participants, 566 responded for a 23.8% overall response rate, and 469 of these respondents were RNs. Most RNs, 96.7%, agreed that easier and quicker access to outside information would benefit delivery of care, and 72.6% said the number of emergency department referrals would decrease. When asked about pre–health information exchange access to patient data, 96.3% said it was problematic. Inpatient discharge summaries were chosen most often by the RNs as a top five desired data element 81.5% of the time. Obtaining outside clinical information has been a challenge without health information exchange, but improved access to this information may lead to improved care. Further study is required to assess experiences with the use of health information exchange.
- 1 September 2012
- Published by Wolters Kluwer Health in CIN: Computers, Informatics, Nursing
- Vol. 30 (9) , 503-509
Perceptions of Health Information Exchange in Home Healthcare
The aim of this study was to understand home healthcare nurses’ current experiences in obtaining outside clinical information at the point of care and the type of clinical information they most desire in their patients’ health information exchange profile. A Web-based survey was deployed to home health workers in New York to learn about their experiences retrieving outside clinical data prior to having access to health information exchange, preferred data elements and sources in their patients’ health information exchange profiles, and how availability of outside clinical data may affect emergency department referrals. Of the 2383 participants, 566 responded for a 23.8% overall response rate, and 469 of these respondents were RNs. Most RNs, 96.7%, agreed that easier and quicker access to outside information would benefit delivery of care, and 72.6% said the number of emergency department referrals would decrease. When asked about pre–health information exchange access to patient data, 96.3% said it was problematic. Inpatient discharge summaries were chosen most often by the RNs as a top five desired data element 81.5% of the time. Obtaining outside clinical information has been a challenge without health information exchange, but improved access to this information may lead to improved care. Further study is required to assess experiences with the use of health information exchange.
- 1 October 2006
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 48 (4) , 426-432
Approaches to Patient Health Information Exchange and Their Impact on Emergency Medicine
- 1 October 2006
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 48 (4) , 426-432
Approaches to Patient Health Information Exchange and Their Impact on Emergency Medicine
- 1 February 1980
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 29 (2) , 146-152
Operation for Chronic Constrictive Pericarditis: Do the Surgical Approach and Degree of Pericardial Resection Influence the Outcome Significantly?
- 1 February 1980
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 29 (2) , 146-152
Operation for Chronic Constrictive Pericarditis: Do the Surgical Approach and Degree of Pericardial Resection Influence the Outcome Significantly?
- 1 September 1978
- Vol. 78 (11) , 1719-21
Surgery for chronic constrictive pericarditis. Does surgical approach and degree of pericardial resection significantly influence outcome?
- 1 September 1978
- Vol. 78 (11) , 1719-21
Surgery for chronic constrictive pericarditis. Does surgical approach and degree of pericardial resection significantly influence outcome?
- Open Access
- 1 July 1978
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 62 (1) , 29-38
A Specific Inhibitor of Complement (C5)-Derived Chemotactic Activity in Serum from Patients with Systemic Lupus Erythematosus
In the course of examining polymorphonuclear leukocyte (PMN) chemotaxis in patients with systemic lupus erythematosus (SLE), we have found a previously undescribed serum inhibitor of complement (C5)-derived chemotactic activity. Serum from a 25-yr-old Black female with untreated SLE, when activated with zymosan, failed completely to attract either her own or normal PMN. Incubation of normal PMN with the patient's serum did not affect their subsequent random motility or chemotactic response toward normal zymosan-treated serum (ZTS). The patient's serum, however, did inhibit the chemotactic activity of normal ZTS and of column-purified C5-derived peptide(s), but had no effect on the chemotactic activity of either the synthetic peptide, N-formylmethionyl leucyl-phenylalanine or a filtrate prepared from a culture of Escherichia coli (bacterial chemotactic factor). The inhibitory activity in the patient's serum resisted heating at 56°C for 30 min and could be separated from C5-derived chemotactic activity in the patient's ZTS (or normal ZTS that had been incubated with the patient's serum) by chromatography on Sephadex G-75. Despite its effect on C5-derived chemotactic activity, the patient's serum did not influence two other C5-derived biologic activities: PMN lysosomal enzyme-releasing activity and PMN-aggregating activity. Chromatography of the patient's serum (65% ammonium sulfate pellet) on Sephadex G-200 yielded three distinct peaks of inhibitory activity. Two were heat labile and exhibited other properties of the previously described chemotactic factor inactivators of normal human serum. The third and most active peak, however, resisted heating at 56°C for 30 min, eluted with an apparent mol wt of 50,000-60,000, and acted specifically on C5-derived chemotactic activity. This uniquely specific, heat-stable inhibitor of C5-derived chemotactic activity has been found thus far in serum from 4 of 11 patients with active SLE and may account, in part, for altered host defenses against infections caused by pyogenic microorganisms.
- 1 July 1978
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 62 (1) , 29-38
Open AccessA Specific Inhibitor of Complement (C5)-Derived Chemotactic Activity in Serum from Patients with Systemic Lupus Erythematosus
In the course of examining polymorphonuclear leukocyte (PMN) chemotaxis in patients with systemic lupus erythematosus (SLE), we have found a previously undescribed serum inhibitor of complement (C5)-derived chemotactic activity. Serum from a 25-yr-old Black female with untreated SLE, when activated with zymosan, failed completely to attract either her own or normal PMN. Incubation of normal PMN with the patient's serum did not affect their subsequent random motility or chemotactic response toward normal zymosan-treated serum (ZTS). The patient's serum, however, did inhibit the chemotactic activity of normal ZTS and of column-purified C5-derived peptide(s), but had no effect on the chemotactic activity of either the synthetic peptide, N-formylmethionyl leucyl-phenylalanine or a filtrate prepared from a culture of Escherichia coli (bacterial chemotactic factor). The inhibitory activity in the patient's serum resisted heating at 56°C for 30 min and could be separated from C5-derived chemotactic activity in the patient's ZTS (or normal ZTS that had been incubated with the patient's serum) by chromatography on Sephadex G-75. Despite its effect on C5-derived chemotactic activity, the patient's serum did not influence two other C5-derived biologic activities: PMN lysosomal enzyme-releasing activity and PMN-aggregating activity. Chromatography of the patient's serum (65% ammonium sulfate pellet) on Sephadex G-200 yielded three distinct peaks of inhibitory activity. Two were heat labile and exhibited other properties of the previously described chemotactic factor inactivators of normal human serum. The third and most active peak, however, resisted heating at 56°C for 30 min, eluted with an apparent mol wt of 50,000-60,000, and acted specifically on C5-derived chemotactic activity. This uniquely specific, heat-stable inhibitor of C5-derived chemotactic activity has been found thus far in serum from 4 of 11 patients with active SLE and may account, in part, for altered host defenses against infections caused by pyogenic microorganisms.